Connect with us:   Email This Page  | Print
Learn more about Neuronetics, developer of the NeuroStar TMS Therapy System.
NeuroStar TMS Therapy<sup>®</sup> System

Transcranial Magnetic Stimulation
Transcranial magnetic stimulation therapy (TMS Therapy) is based on knowledge of physical principles dating back nearly 175 years. In 1831, Michael Faraday discovered that a magnetic field could be converted into an electrical current. That discovery has been applied to create a powerful and focused magnetic treatment coil which can be used to stimulate the brain.

Since the 1980s, transcranial magnetic stimulation has been used to study the nerve fibers that carry information about movements from the brain to the spinal cord and onto the muscles. In the late 1990s physicians began to explore the therapeutic potential of transcranial magnetic stimulation for the treatment of a variety of diseases, with depression being the most thoroughly studied to date. Since then, 30 or more randomized, controlled trials studying transcranial magnetic stimulation as a treatment for depression have been published by investigators throughout the world 1.

Transcranial Magnetic Stimulation for the Treatment of Depression
Transcranial magnetic stimulation for the treatment of depression is a short outpatient procedure which uses a focused pulsed magnetic field to stimulate nerve cells within the area of the brain thought to control mood. TMS Therapy is available by prescription only and performed in a psychiatrist's office under the supervision of a psychiatrist while the patient remains awake and alert.

The treating clinician positions a treatment coil over the left prefrontal cortex, the part of the brain thought to be involved with mood regulation. Through the treatment coil, the NeuroStar TMS Therapy system generates a highly concentrated, magnetic field which turns on and off rapidly. This magnetic field is the same type and strength as the magnetic field produced by a magnetic resonance imaging (MRI) machine. Learn how it works.

References:

  1. Schutter, D. (2009). "Antidepressant efficacy of high-frequency transcranial magnetic stimulation over the left dorsolateral prefrontal cortex in double-blind sham-controlled designs: a meta-analysis." Psychological Medicine 39: 65-75.
Refer a Patient for Treatment
NeuroStar TMS Therapy may be right for your patients suffering from major depression. Refer them here.
Find a Provider

Become a NeuroStar TMS Therapy Provider
Provide your patients the new way back from depression with NeuroStar TMS Therapy®. Contact us to find out how you can bring NeuroStar into your workplace.
Contact Us


* NeuroStar TMS Therapy® is indicated for the treatment of Major Depressive Disorder in adult patients who have failed to achieve satisfactory improvement from one prior antidepressant medication at or above the minimal effective dose and duration in the current episode. Click here for full prescribing and safety information

Copyright © 2010 Neuronetics. All Rights Reserved Sitemap  | Privacy Policy  | Terms and Conditions  | Glossary
 

You are leaving www.NeuroStarTMS.com, a website of Neuronetics. Links to all outside websites are provided as a resource to our visitors. Neuronetics accepts no responsibility for the content of other websites.

Click here to continue.